Artificial Intelligence System in Medical Regulation
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON · Jun 28, 2021
Trial Information
Current as of July 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how artificial intelligence (AI) can improve emergency medical communication centers, which are places that handle emergency calls for medical help. The goal is to make these centers better at managing calls by using AI to assess how serious a situation is, figure out the best way to help patients, and use resources more efficiently. This could mean faster and more accurate responses when someone needs urgent medical care.
Anyone who makes a call to these emergency centers can potentially be part of this study, as long as they are willing to participate. However, if someone does not want to be a part of the trial, they will not be included. Participants can expect that their calls will be handled using this new AI system, which aims to provide more personalized and effective responses to their needs. Overall, this trial is an exciting step towards using technology to improve emergency medical services for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patient which call the emergency medical communication centres
- Exclusion Criteria:
- • patient opposed to the study
About Centre Hospitalier Universitaire De Besancon
The Centre Hospitalier Universitaire de Besançon (CHU de Besançon) is a leading academic medical center located in Besançon, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Besançon focuses on a wide range of medical disciplines, fostering collaboration between healthcare professionals and researchers to develop new therapeutic strategies and improve patient outcomes. With a commitment to rigorous scientific standards and ethical practices, the institution plays a vital role in translating research findings into practical applications, ultimately enhancing the quality of care provided to the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials